TrialScientific reports2022
Attention neuroenhancement through tDCS or neurofeedback: a randomized, single-blind, controlled trial.
Gabriel Gaudencio Rêgo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it